Delivery Order HHSN261201000063I-HHSN26100001
Award Date 8/26/10
Potential Completion Date 9/30/14
Potential Value $35K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Ann Arbor, MI 48109, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order issued under the National Cancer Institute's Cancer Genome Atlas Program Tissue Purchase contract. The $388,593.75 firm fixed-price award to the Regents of the University of Michigan was made to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The award was funded through the American Recovery and Reinvestment Act (ARRA) and has a performance period ending on March 31, 2015. No set-aside designation was used for...
- This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson) in support of the Cancer Genome Atlas (TCGA) program. The $146,302 firm fixed price delivery order contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ vehicle. The contract requires MD Anderson, a large academic cancer center, to provide tissue samples and data from...
- This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. for the Cancer Genome Atlas (TCGA) program. The $1,337,077.50 contract is to provide tissue samples and data from various types of cancer for the TCGA program, which aims to characterize the genomic changes involved in cancer. The award is not associated with a set-aside program. This delivery order is part of...
- This federal contract award was issued by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson) to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery vehicle, with a ceiling value of $18,762.50 and a completion date of September 30, 2014. This contract is not associated with any...
- This federal contract award, valued at $102,282.25, was issued by the National Cancer Institute (NCI) to the University of Miami Office of Research Administration - School of Medicine Division. The award is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract. The contract supports the ARRA-funded Cancer Genome Atlas (TCGA) program, which collects tissue samples and data from various types of cancer. There is no set-aside designation for this...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to Yale University. The contract is to support the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer, as part of the American Recovery and Reinvestment Act (ARRA). The contract has a ceiling value of $76,875 and a period of performance ending on March 31, 2015. This contract was...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson). The contract supports the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various cancer types. The award ceiling value is $562,875.00 and the period of performance runs from April 30, 2010 to March 31, 2015. This delivery order is part of the...
- This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Regents of the University of California, San Francisco (UCSF) for the Cancer Genome Atlas (TCGA) program. The contract, valued at $24,087.50, is for the acquisition of tissue samples and data from various types of cancer to support the TCGA program, which is part of the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation and is a firm fixed-price type. UCSF, as...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The total ceiling value of the contract is $42,000.00. This contract is part of the NCI's Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract...
- This is a $161,250 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to The Johns Hopkins University (JHU) for the Cancer Genome Atlas (TCGA) program. The order is part of a larger NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The work involves providing tissue samples and data from various cancer types to support the TCGA, a collaborative effort to accelerate the understanding of the molecular basis of cancer through the application of genome...